Pzena Investment Management LLC Sells 45,502 Shares of Henry Schein, Inc. $HSIC

Pzena Investment Management LLC cut its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 4.7% during the second quarter, Holdings Channel.com reports. The firm owned 920,231 shares of the company’s stock after selling 45,502 shares during the period. Pzena Investment Management LLC’s holdings in Henry Schein were worth $67,223,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Alliancebernstein L.P. boosted its stake in shares of Henry Schein by 21.9% during the first quarter. Alliancebernstein L.P. now owns 218,340 shares of the company’s stock valued at $14,954,000 after purchasing an additional 39,188 shares in the last quarter. Farther Finance Advisors LLC boosted its stake in shares of Henry Schein by 237.3% during the first quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company’s stock valued at $186,000 after purchasing an additional 1,898 shares in the last quarter. Great Lakes Advisors LLC bought a new position in shares of Henry Schein during the first quarter valued at approximately $4,477,000. State of Alaska Department of Revenue boosted its stake in shares of Henry Schein by 2.8% during the first quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company’s stock valued at $1,000,000 after purchasing an additional 395 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. boosted its stake in shares of Henry Schein by 5.2% during the first quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company’s stock valued at $941,000 after purchasing an additional 678 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Trading Down 2.2%

NASDAQ:HSIC opened at $63.17 on Monday. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49. The firm has a fifty day simple moving average of $67.48 and a 200-day simple moving average of $68.80. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $7.66 billion, a P/E ratio of 20.38, a PEG ratio of 2.08 and a beta of 0.81.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The company had revenue of $3.24 billion for the quarter, compared to analyst estimates of $3.22 billion. During the same quarter in the previous year, the firm posted $1.23 earnings per share. The company’s quarterly revenue was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, equities research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Wall Street Analysts Forecast Growth

HSIC has been the subject of several recent analyst reports. Evercore ISI upgraded shares of Henry Schein from an “in-line” rating to an “outperform” rating and set a $83.00 target price for the company in a research note on Tuesday, August 26th. UBS Group lowered their target price on shares of Henry Schein from $75.00 to $70.00 and set a “neutral” rating for the company in a research note on Wednesday, August 6th. Stifel Nicolaus restated a “hold” rating and issued a $75.00 target price (down from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. Barrington Research restated an “outperform” rating and issued a $78.00 target price on shares of Henry Schein in a research note on Tuesday, September 23rd. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Henry Schein in a research note on Wednesday, October 8th. Five investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $76.67.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.